Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV
Authors:
- Lucy F. LeeLLLucy F. Lee
- Blanca LupianiBLBlanca Lupiani
- Robert F. SilvaRSRobert F. Silva
- Hsing-Jien KungHKHsing-Jien Kung
- Sanjay M. ReddySRSanjay M. Reddy
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Serotype 1 Viruses Modified by Backpassage or Insertional Mutagenesis: Approaching the Threshold of Vaccine Efficacy in Marek's DiseaseAvian Diseases, 2004
- The Efficacy of Recombinant Fowlpox Vaccine Protection Against Marek's Disease: Its Dependence on Chicken Line and B HaplotypeAvian Diseases, 2004
- Protection and Synergism by Recombinant Fowl Pox Vaccines Expressing Multiple Genes from Marek's Disease VirusAvian Diseases, 2003
- Chicken industry strategies for control of tumor virus infectionsPoultry Science, 1998
- The Glycoprotein B Genes of Marek's Disease Virus Serotypes 2 and 3: Identification and Expression by Recombinant Fowlpox VirusesVirology, 1994
- New Serotype 2 and Attenuated Serotype 1 Marek's Disease Vaccine Viruses: Selected Biological and Molecular CharacteristicsAvian Diseases, 1987
- Polyvalent Marek's disease vaccines: Safety, efficacy and protective synergism in chickens with maternal antibodies1Avian Pathology, 1984
- Characterisation of two highly oncogenic strains of Marek's disease virus12Avian Pathology, 1982
- The Attenuation, with Loss of Oncogenicity, of the Herpes-type Virus of Marek's Disease (Strain hprs-16) on Passage in Cell CultureJournal of General Virology, 1969
- Immunization against Marek's Disease using a Live Attenuated VirusNature, 1969